🇨🇦 Amifostine administered subcutaneously in Canada

Amifostine administered subcutaneously (Amifostine administered subcutaneously) regulatory status in Canada.

Marketing authorisation

Amifostine administered subcutaneously in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Amifostine administered subcutaneously approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Amifostine administered subcutaneously in Canada?

Mt. Sinai Medical Center, Miami is the originator. The local marketing authorisation holder may differ — check the official source linked above.